Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Effect Site Remifentanil Concentration for Smooth Extubation After Thyroid Surgery

NCT03218124 is registered in ClinicalTrials.gov with University of Cagliari as lead sponsor.

NCT NCT03218124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03218124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Effect Site Remifentanil Concentration for Smooth Extubation After Thyroid Surgery
Lead sponsor
University of Cagliari
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2017
Completion date
July 1, 2018
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia